Form D · Biotechnology
Safeguard Biosystems Holdings Ltd
London, X0 · CIK 0001780596
Offering snapshot reported Jun 24, 2019 · SEC filing
- Reported sold
- $3.5M Offering amount: $3.7M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $200 Reported outside-investor minimum
- First sale
- Jun 4, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 24, 2019 | Initial | $3,500,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-342623
Source: Form D, filed Jun 24, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| George Richard Aaron | Executive |
| Anthony James Culverwell | Director |
| Wayne Fox | Director |
| Arthur Rubenstein | Director |
| Howard Mark Sherman | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6 Th Floor, Quadrant House 4 Thomas More Street
London, X0, E1W 1YW
London, X0, E1W 1YW